trending Market Intelligence /marketintelligence/en/news-insights/trending/7Cjwc6IstdwxhxJWi6XqsA2 content esgSubNav
In This List

J&J unit sued in the UK for allegedly selling faulty hip implants

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


J&J unit sued in the UK for allegedly selling faulty hip implants

DePuy International Ltd., a unit of Johnson & Johnson, is being sued for selling faulty hip implants in the U.K., Bloomberg News reported Oct. 16.

The lawsuit alleges that the implants released metal particles into the body causing multiple health issues, the news outlet reported, citing lawyers for the 341 claimants in the case.

The first stage of the lawsuit will determine the liability of DePuy, and if the claims are proven there will be more court hearings to decide the compensation to be paid.

Depuy's lawyers responded to the claims by stating that the company was not at fault and "the burden of proving that the product was defective and that the defect caused harm rests on the claimants."

The J&J unit was previously sued in the U.S. where the company was ordered to pay about $500 million in damages.

The company is facing 9,000 lawsuits over marketing the flawed hip implants, which it stopped selling in 2013 after the U.S. Food and Drug Administration tightened regulations on artificial-hip implants.